Analysis of clonal NK cell populations using single-cell transcriptomics data
- Authors: Ustiuzhanina M.O.1,2,3, Kovalenko E.I.1
-
Affiliations:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Skolkovo Institute of Science and Technology
- Pirogov Russian National Research Medical University
- Issue: Vol 28, No 4 (2025)
- Pages: 887-892
- Section: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/333246
- DOI: https://doi.org/10.46235/1028-7221-17245-AOC
- ID: 333246
Cite item
Full Text
Abstract
Natural killer (NK) cells represent a critical component of antiviral immunity, demonstrating remarkable adaptability during infections such as human cytomegalovirus (hCMV) and SARS-CoV-2. Recent advances in single-cell transcriptomics have revealed the clonally expanding NK cell populations with distinct functional profiles, blurring the traditional boundaries between innate and adaptive immunity. However, the functional heterogeneity and immunological significance of these clones remain incompletely understood. Our aim was to dissect clonal NK cell heterogeneity using published scRNA-seq datasets from hCMV-seropositive, seronegative, and COVID-19 patients, focusing on cluster-specific gene expression patterns. Our computational pipeline employed Seurat-based integration and high-resolution clustering of datasets from hCMV-seropositive (n = 5) and seronegative (n = 2) donors, along with COVID-19 patients (n = 2). We analyzed datasets using Seurat 5 in R. Quality-controlled data were normalized (SCTransform), integrated (batch-corrected), and clustered (UMAP). Differential gene expression (Wilcoxon test, log2FC > 0.25, p-adj < 0.05) and annotation were performed. In hCMV-seropositive individuals, we identified 12 transcriptionally distinct NK cell clusters exhibiting KLRC2 (NKG2C)-dependent organization, with specific clones showing either enhanced cytotoxic potential (marked by GZMB/GZMA upregulation), or unique inhibitory receptor profiles (variable KIR expression patterns). The hCMV-seronegative cohort displayed a simpler clonal structure with 9 clusters showing reduced KIR diversity but maintained distinct effector gene signatures. Analysis of COVID-19 patients revealed divergent clonal patterns: one patient showed reduced KLRC2 variability with prominent KLRC1 (NKG2A) expression, while another exhibited KIR heterogeneity without KLRC2 variation. Our analysis reveals distinct clonal NK cell populations in hCMV and COVID-19 contexts, characterized by divergent expression of activating and inhibitory receptors. These findings demonstrate infection-specific dynamics of clonal NK cell populations, highlighting their adaptive potential through differential receptor expression in antiviral responses.
Full Text
##article.viewOnOriginalSite##About the authors
Maria O. Ustiuzhanina
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Skolkovo Institute of Science and Technology; Pirogov Russian National Research Medical University
Author for correspondence.
Email: mashaust1397@gmail.com
ORCID iD: 0000-0003-3378-6508
Postgraduate Student, Department of Cellular and Melecular Biology, Center of Life Sciences, Junior Researcher, Department of Genomics of Adaptive Immunity, Laboratory of Immunosequencing Methods, Junior Researcher, Laboratory of Biomarkers, Institute of Translational Medicine
Russian Federation, 16/10 Miklouho-Maclay St, GSP-7, Moscow, 117997; Moscow; MoscowElena I. Kovalenko
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Email: lenkovalen@mail.ru
ORCID iD: 0000-0001-8119-8247
PhD (Biology), Senior Researcher, Department of Immunology, Laboratory of Cell Interactions
Russian Federation, 16/10 Miklouho-Maclay St, GSP-7, Moscow, 117997References
- Béziat V., Liu L.L., Malmberg J.A., Ivarsson M.A., Sohlberg E., Björklund A.T., Retière C., Sverremark-Ekström E., Traherne J., Ljungman P., Schaffer M., Price D.A., Trowsdale J., Michaëlsson J., Ljunggren H.G., Malmberg KJ. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood, 2013, Vol. 121, no. 14, pp. 2678-2688.
- Grassmann S., Pachmayr L.O., Leube J., Mihatsch L., Andrae I., Flommersfeld S., Oduro J., Cicin-Sain L., Schiemann M., Flossdorf M., Buchholz V.R. Distinct surface expression of activating receptor Ly49H drives differential expansion of NK cell clones upon murine cytomegalovirus infection. Immunity, 2019, Vol. 50, no. 6, pp. 1391-1400.e4.
- Gumá M., Budt M., Sáez A., Brckalo T., Hengel H., Angulo A., López-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood, 2006, Vol. 107, no. 9, pp. 3624-3631.
- Ludwig L.S., Lareau C.A., Ulirsch J.C., Christian E., Muus C., Li L.H., Pelka K., Ge W., Oren Y., Brack A., Law T., Rodman C., Chen J.H., Boland G.M., Hacohen N., Rozenblatt-Rosen O., Aryee M.J., Buenrostro J.D., Regev A., Sankaran V.G. Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics. Cell, 2019, Vol. 176, no. 6, pp. 1325-1339.e22.
- Maucourant C., Filipovic I., Ponzetta A., Aleman S., Cornillet M., Hertwig L., Strunz B., Lentini A., Reinius B., Brownlie D., Cuapio A., Ask EH., Hull R.M., Haroun-Izquierdo A., Schaffer M., Klingström J., Folkesson E., Buggert M., Sandberg J.K., Eriksson L.I., Rooyackers O., Ljunggren H.G., Malmberg K.J., Michaëlsson J., Marquardt N., Hammer Q., Strålin K., Björkström NK. Natural killer cell immunotypes related to COVID-19 disease severity. Sci. Immunol., 2020, Vol. 5, no. 50, eabd6832. doi: 10.1126/sciimmunol.abd6832.
- Rückert T., Lareau C..A, Mashreghi M.F., Ludwig L.S., Romagnani C. Clonal expansion and epigenetic inheritance of long-lasting NK cell memory. Nat. Immunol., 2022, Vol. 23, no. 11, pp. 1551-1563.
- Ustiuzhanina M.O., Streltsova M.A., Timofeev N.D., Kryukov M.A., Chudakov D.M., Kovalenko E.I. Autologous T-cell-free antigen presentation system unveils hCMV-specific NK cell response. Cells, 2024, Vol. 13, no. 6, 530. doi: 10.3390/cells13060530.
- Ustiuzhanina M.O., Vavilova J.D., Boyko A.A., Streltsova M.A., Kust S.A., Kanevskiy L.M., Sapozhnikov A.M., Iskhakov R.N., Gubernatorova E.O., Drutskaya M.S., Bychinin M.V., Zhukova O.A., Novikova O.N., Sotnikova A.G., Yusubalieva G.M., Baklaushev V.P., Kovalenko E.I. Coordinated Loss and Acquisition of NK cell surface markers accompanied by generalized cytokine dysregulation in COVID-19. Int. J. Mol. Sci., 2023, Vol. 24, no. 3, 1996. doi: 10.3390/ijms24031996.
- Ustiuzhanina M.O., Boyko A.A., Vavilova J.D., Siniavin A.E., Streltsova M.A., Astrakhantseva I.V., Drutskaya M.S., Chudakov D.M., Kovalenko E.I. The Antigen-Specific Response of NK Cells to SARS-CoV-2 Correlates With KIR2DS4 Expression. J. Med. Virol., 2024, Vol. 96, no. 11, e70057. doi: 10.1002/jmv.70057.
- Varchetta S., Mele D., Oliviero B., Mantovani S., Ludovisi S., Cerino A., Bruno R., Castelli A., Mosconi M., Vecchia M., Roda S., Sachs M., Klersy C., Mondelli M.U. Unique immunological profile in patients with COVID-19. Cell. Mol. Immunol. 2021, Vol. 18, no. 3, pp. 604-612.
- Witkowski M., Tizian C., Ferreira-Gomes M., Niemeyer D., Jones T.C., Heinrich F., Frischbutter S., Angermair S., Hohnstein T., Mattiola I., Nawrath P., Mc Ewen S., Zocche S., Viviano E., Heinz G.A., Maurer M., Kölsch U., Chua R.L., Aschman T., Meisel C., Radke J., Sawitzki B., Roehmel J., Allers K., Moos V., Schneider T., Hanitsch L., Mall M.A., Conrad C., Radbruch H., Duerr CU., Trapani J.A., Marcenaro E., Kallinich T., Corman V.M., Kurth F., Sander L.E., Drosten C., Treskatsch S., Durek P., Kruglov A., Radbruch A., Mashreghi M.F., Diefenbach A. Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells. Nature, 2021, Vol. 600, no. 7888, pp. 295-301.
Supplementary files
